REPSOL
Healthcare polyolefins portfolio expanded / New grades of LDPE offer wide ranges of fluidity and density
 Upgrades at its plant in Sines / Portugal allow Repsol to integrate the new grades into its range (Photo: Repsol) |
Spanish energy and chemicals company Repsol (Madrid; www.repsol.com) has unveiled its expanded range of “Repsol Healthcare” polyolefin products for pharmaceutical packaging and medical devices. The company is incorporating new LDPE grades into its range, thanks to the upgrades to its LDPE plant in Sines / Portugal. The Sines facility now joins Repsol’s other pharma units in Tarragona / Spain – where it produces LDPE, polypropylene and HDPE – as well as in Puertollano / Spain, which makes EVA copolymers.
The new LDPE grades offer processors a variety of alternatives designed to meet their needs on both melt flow index (0.3-20 g/10 min) and density. Processors are able to manufacture novel containers, parts and films using lamination, blown film extrusion and injection.
The new grades were launched in November 2019 at the “Compamed” (www.compamed-tradefair.com) exhibition in Düsseldorf / Germany.
The new LDPE grades offer processors a variety of alternatives designed to meet their needs on both melt flow index (0.3-20 g/10 min) and density. Processors are able to manufacture novel containers, parts and films using lamination, blown film extrusion and injection.
The new grades were launched in November 2019 at the “Compamed” (www.compamed-tradefair.com) exhibition in Düsseldorf / Germany.
04.02.2020 Plasteurope.com [243738-0]
Published on 04.02.2020